Shares of Ginkgo Bioworks (NYSE:DNA) soared over 20% in Wednesday’s trading session. The increase can be attributed to the news of Cathie Wood adding 146,200 shares of the company to its fund.
Is DNA Stock a Buy?
Turning to Wall Street, it appears that analysts share Cathie Wood’s optimism. DNA stock has a Strong Buy consensus rating based on four Buys assigned in the past four months. The average DNA stock price target of $10.83 implies 212.1% upside potential.
